Cargando…

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients

Some years ago, excipients were considered inert substances irrelevant in the absorption process. However, years of study have demonstrated that this belief is not always true. In this study, the reasons for a bioequivalence failure between two formulations of silodosin are investigated. Silodosin i...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Álvarez, Isabel, Sánchez-Dengra, Bárbara, Rodriguez-Galvez, Raquel, Ruiz-Picazo, Alejandro, González-Álvarez, Marta, García-Arieta, Alfredo, Bermejo, Marival
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783061/ https://www.ncbi.nlm.nih.gov/pubmed/36559059 http://dx.doi.org/10.3390/pharmaceutics14122565

Ejemplares similares

Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019)

An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
por: Gonzalez-Alvarez, Isabel, et al.
Publicado: (2021)

Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses
por: Bermejo, Marival, et al.
Publicado: (2019)

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
por: Figueroa-Campos, Andrés, et al.
Publicado: (2020)

One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products
por: Prieto-Escolar, Mercedes, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood–Brain Barrier in Patients with Glioblastoma
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2023)

pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis
por: González-Alvarez, Isabel, et al.
Publicado: (2021)

Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development
por: Miranda, Claudia, et al.
Publicado: (2022)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020)

Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets
por: Al-khattawi, Ali, et al.
Publicado: (2014)

Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water
por: Takagi, Toshihide, et al.
Publicado: (2023)

Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2019)

Excipient-drug pharmacokinetic interactions: Effect of disintegrants on efflux across excised pig intestinal tissues
por: Gerber, Werner, et al.
Publicado: (2018)

Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies
por: Ozgenc, Emre, et al.
Publicado: (2022)

Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG)
por: Yamada, Mizuki, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Focus on Silodosin: Pros and Cons of Uroselectivity
por: Califano, Gianluigi, et al.
Publicado: (2020)

Levocetirizine Oral Disintegrating Tablet: A Randomized Open‐Label Crossover Bioequivalence Study in Healthy Japanese Volunteers
por: Ino, Hiroko, et al.
Publicado: (2020)

Long-Circulating Hyaluronan-Based Nanohydrogels as Carriers of Hydrophobic Drugs
por: Di Meo, Chiara, et al.
Publicado: (2018)

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
por: Teruel, Adrian H., et al.
Publicado: (2020)

A Suspected Case of Silodosin-Induced Erythroderma
por: Liu, Annie, et al.
Publicado: (2015)

Silodosin-associated intraoperative floppy iris syndrome
por: Chatterjee, Samrat, et al.
Publicado: (2017)

Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State—A Case Study
por: Mangas-Sanjuán, Víctor, et al.
Publicado: (2023)

Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single‐Dose Crossover Studies in Healthy Japanese Men
por: Kurata, Akifumi, et al.
Publicado: (2022)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
por: Rahman, Md Jawaid, et al.
Publicado: (2017)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
por: Bermejo, Marival, et al.
Publicado: (2020)

A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets
por: Alonso, Tatiana R, et al.
Publicado: (2018)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida, Masaki, et al.
Publicado: (2011)

Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
por: Sakata, Koichi, et al.
Publicado: (2012)

Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs
por: Ren, Ping, et al.
Publicado: (2023)

Development of Novel Tamsulosin Pellet-Loaded Oral Disintegrating Tablet Bioequivalent to Commercial Capsule in Beagle Dogs Using Microcrystalline Cellulose and Mannitol
por: Cho, Hyuk Jun, et al.
Publicado: (2023)

Excipients
Publicado: (1878)

Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs
por: de Souza Teixeira, Leonardo, et al.
Publicado: (2020)

An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies
por: Gundogdu, Evren, et al.
Publicado: (2022)

Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
por: Musuc, Adina Magdalena, et al.
Publicado: (2021)

Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union
por: Paixão, Paulo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_70a7hmavvv9iit6jihgdhe22a7